← Evidence map

ArticleThe Journal of antimicrobial chemotherapy2014

Simvastatin increases the in vivo activity of the first-line tuberculosis regimen.

Ciaran Skerry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

75 papers cite itlatest 60 shown

2014
…
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24855121